𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The tumor promoter TPA enhances benzo[a]pyrene and benzo[a]pyrene diolepoxide mutagenesis in Big Blue® mouse skin

✍ Scribed by Marian L. Miller; Kersi Vasunia; Glenn Talaska; Anastasia Andringa; Johan de Boer; Kathleen Dixon

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
146 KB
Volume
35
Category
Article
ISSN
0893-6692

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The involvement of a diol-epoxide in the
The involvement of a diol-epoxide in the metabolic activation of benzo(a)pyrene in human bronchial mucosa and in mouse skin
✍ P. L. Grover; A. Hewer; K. Pal; P. Sims 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 French ⚖ 569 KB

## Abstract DNA has been isolated from human bronchial segments that have been treated in short‐term organ culture with ^3^H‐labelled benzo(a)pyrene. DNA has also been isolated from mouse skin treated with ^3^H‐labelled samples of benzo(a)pyrene, with the related radioactive 4,5‐, 7,8‐ and 9,10‐dih

Factors affecting the bioavailability of
Factors affecting the bioavailability of benzo[a]pyrene from oils in mouse skin: Oil viscosity, grooming, activity and its prevention
✍ A. J. Ingram; R. Lee; J. C. Phillips 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 784 KB

In the main study, tritium-labelled benzo [a]pyrene ([3H]BaP) was added to oils of a wide range of viscosity (from 13.5 to ca. 8000 cSt at 40°C) and these were applied once to mouse skin under conditions where grooming was either allowed or prevented. The binding of ['HIBaP to epidermal protein and

System Issues: Mutagenic response of the
System Issues: Mutagenic response of the endogenous hprt gene and lacl transgene in benzo[a]pyrene-treated Big Blue™ B6C3F1 mice
✍ Thomas R. Skopek; Kristy L. Kort; Deborah R. Marino; Lakshmi V. Mittal; Diane R. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 807 KB

Big Blue@ (BB) and generic B6C3F1 mice were given one to three i.p. injections of 50 mg/kg benzo[a]pyrene (B[a]P) in DMSO every other day to achieve cumulative doses of 50 to 150 mg/kg. Three weeks after treatment, the mutation frequency at the endogenous hprt gene and lac/ transgene was measured in

Combined subcarcinogenic benzo[a]pyrene
Combined subcarcinogenic benzo[a]pyrene and UVA synergistically caused high tumor incidence and mutations in H-ras gene, but not p53, in SKH-1 hairless mouse skin
✍ Yongyin Wang; Dayuan Gao; David P. Atencio; Evangeline Perez; Rao Saladi; Julian 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 160 KB

## Abstract Combined subcarcinogenic doses of benzo[__a__]pyrene (BaP) and UVA induced H‐__ras,__ but not __p53,__ gene mutations 8 weeks before tumor emergence in SKH‐1 mice. Neither UVA (40 kJ/m^2^) nor BaP (8 nmol) induced any tumors after mice were topically treated 3 times/week for 25 weeks. H